Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
---|
06/09/2009 | US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes |
06/09/2009 | US7544667 Hypocholesterolemic compounds |
06/04/2009 | WO2009069792A1 Amide compounds and plant disease controlling method using same |
06/04/2009 | WO2009069736A1 Nitrogenated compound |
06/04/2009 | WO2009068177A1 DERIVATIVES OF 4-(2-AMINO-1 -HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
06/04/2009 | US20090143590 Process for the Preparation of Montelukast and its Salts |
06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
06/04/2009 | US20090143427 4-Oxoquinoline derivatives |
06/04/2009 | US20090143425 Compounds affecting gap junction activity |
06/04/2009 | US20090143389 Heterocyclic inhibitors of mek and methods of use thereof |
06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
06/04/2009 | US20090143354 P2X7 Receptor Antagonists and Their Use |
06/04/2009 | US20090142554 Yellow Azo Dyes for Ink Jet Printing |
06/04/2009 | US20090142297 5-substituted isoindoline compounds |
06/04/2009 | CA2706333A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the .beta.2 adrenergic receptor |
06/03/2009 | EP2065372A1 Antitumor agent for undifferentiated gastric cancer |
06/03/2009 | EP2064200A1 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
06/03/2009 | EP2064185A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
06/03/2009 | EP1613319B1 Substituted phenyl acetamides and their use as protease inhibitors |
06/03/2009 | CN101448790A Method of preparing 4-halogenated quinoline intermediates |
06/03/2009 | CN100494177C Bi-amido heterocyclic derivative with antitumour activity and its preparation method and use |
06/03/2009 | CN100494176C Method for extracting alkali metals or calcium salt of halogen or haloalkyl substituted 2-hydroxy pyridine, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
06/02/2009 | US7541467 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET) |
06/02/2009 | US7541466 Tetrahydroisoquinoline derivatives for treating protein trafficking diseases |
06/02/2009 | US7541465 Substituted 2-aminoacetamides and the use thereof |
06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
05/28/2009 | WO2009065503A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
05/28/2009 | WO2009030467A3 Saturated and insaturated bi- or tricyclic aryloxyacetamide derivatives and their use as fungicides |
05/28/2009 | WO2009027482A3 Tsh receptor antagonizing tetrahydroquinoline compounds |
05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
05/28/2009 | US20090137567 Methods for Treating Blood Disorders |
05/28/2009 | US20090137564 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, A Process for Their Production and Their Use as Anti-inflammatory Agents |
05/28/2009 | US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
05/28/2009 | US20090136561 Non-peptidyl agents with pHSP20-like activity, and uses thereof |
05/28/2009 | CA2705410A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
05/27/2009 | EP2062959A2 Novel red electroluminescent compounds and organic electroluminescent device using the same |
05/27/2009 | EP2062958A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
05/27/2009 | EP2062907A2 Metal coordination compound, luminescence device and display apparatus |
05/27/2009 | EP2062901A1 Fluoroboron compound having aromatic ring or salt thereof, and process for production of compound having cyclic ether-fused aromatic ring by using the same |
05/27/2009 | EP2062880A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
05/27/2009 | EP2061466A2 4-thio substituted quinoline and naphthyridine compounds |
05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
05/27/2009 | CN101443314A Aminoquinolones as GSK-3 inhibitors |
05/27/2009 | CN101443313A Quinoline derivatives and their use as pesticides |
05/27/2009 | CN101443009A Antitumor agent for thyroid cancer |
05/27/2009 | CN101443006A Novel benzylamine derivatives as CETP inhibitors |
05/27/2009 | CN101440063A Preparation of piperaquini phosphatis |
05/27/2009 | CN101440062A Synthesis of N-acyl-8-amino quinoline derivatives and use thereof as fluorescent molecular probe |
05/27/2009 | CN100491354C Quinoline kind iriyellowsin electronic isostere and its preparation process and use |
05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
05/26/2009 | US7538221 Polymorphs of racemic, dextrorotatory, and levorotatory enantioners of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid hydrochloride and mesylate salts |
05/26/2009 | US7538121 Vanilloid receptor modulators |
05/26/2009 | CA2387201C Tetrahydroquinoline derivatives |
05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
05/22/2009 | WO2009063070A2 Quinoline derivatives and their use as tyrosine kinase inhibitors |
05/22/2009 | WO2009062289A1 Inhibitors of human immunodeficiency virus replication |
05/22/2009 | WO2009062285A1 Inhibitors of human immunodeficiency virus replication |
05/22/2009 | WO2009006861A3 A method for isolation and purification of montelukast |
05/22/2009 | WO2008135671A3 Derivatives of the aminated hydroxyquinoline class for treating cancers |
05/22/2009 | WO2007117778A9 Quinolones useful as inducible nitric oxide synthase inhibitors |
05/22/2009 | CA2707418A1 Inhibitors of human immunodeficiency virus replication |
05/22/2009 | CA2705820A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
05/22/2009 | CA2705318A1 Inhibitors of human immunodeficiency virus replication |
05/21/2009 | US20090131461 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
05/21/2009 | US20090131456 Caspase inhibitors and uses thereof |
05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
05/21/2009 | US20090131279 Nucleic acid fluorescent stains |
05/21/2009 | US20090128009 Materials for organic electroluminescence devices |
05/20/2009 | EP2059510A2 Sox-based kinase sensor |
05/20/2009 | EP2059509A2 Process for the preparation of montelukast, and intermediates therefor |
05/20/2009 | EP1270549B1 Polymer-immobilized alpha-iminoester |
05/20/2009 | CN101437920A Electroluminescent material containing an organic luminescent substance |
05/20/2009 | CN101437811A Quinoline derivatives |
05/20/2009 | CN101437801A Process for production of 4-oxoquinoline compound |
05/20/2009 | CN101437785A Method for producing 4-oxoquinoline compound |
05/20/2009 | CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN101434573A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
05/20/2009 | CN100488950C Use of chemotherapeutic agents |
05/19/2009 | US7534915 Non-symmetrical gelling agent |
05/19/2009 | US7534891 Quinoline derivatives as H3R inverse agonists |
05/19/2009 | US7534890 For example, 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-phenylmethoxy-(1H)-quinolin-2-one benzoate; beta-selective adrenoceptor agonists with potent bronchodilator activity |
05/19/2009 | US7534889 5-HT4 receptor agonist compounds |
05/19/2009 | US7534814 Mutilin derivatives and their use as antibacterials |
05/19/2009 | US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
05/19/2009 | CA2368059C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
05/19/2009 | CA2209167C Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
05/14/2009 | WO2009060945A1 Combination of anti-angiogenic substance and anti-tumor platinum complex |
05/14/2009 | WO2009060835A1 Novel ubiquilin-binding small molecule |
05/14/2009 | WO2009060209A1 6,6-fused bicyclic aromatic compounds and their therapeuti use |
05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
05/14/2009 | US20090124625 Novel alkynyl derivatives as modulators of metatropic glutamate receptors |
05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
05/14/2009 | CA2704000A1 Combination of anti-angiogenic substance and anti-tumor platinum complex |
05/13/2009 | EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor |
05/13/2009 | EP2056823A2 8-hydroxyquinoline compounds and methods thereof |
05/13/2009 | CN101432268A Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the ss2 adrenergic receptor |